Search hospitals > Illinois > Elmhurst
Elmhurst Memorial Hospital
Claim this profileElmhurst, Illinois 60126
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Adenocarcinoma
91 reported clinical trials
14 medical researchers
Summary
Elmhurst Memorial Hospital is a medical facility located in Elmhurst, Illinois. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Prostate Cancer, Adenocarcinoma and other specialties. Elmhurst Memorial Hospital is involved with conducting 91 clinical trials across 148 conditions. There are 14 research doctors associated with this hospital, such as Brian C. Myre, Maria I. Quejada, Samir D. Undevia, and Sania S. Raza.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Brian C. MyreElmhurst Memorial Hospital5 years of reported clinical research
Studies Cancer
Studies Renal Cell Carcinoma
7 reported clinical trials
28 drugs studied
Maria I. QuejadaElmhurst Memorial Hospital9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
7 drugs studied
Samir D. UndeviaElmhurst Memorial Hospital9 years of reported clinical research
Studies Ovarian Cancer
Studies Skin Cancer
3 reported clinical trials
23 drugs studied
Sania S. RazaElmhurst Memorial Hospital4 years of reported clinical research
Studies Adenocarcinoma
Studies Colorectal Cancer
2 reported clinical trials
11 drugs studied
Clinical Trials running at Elmhurst Memorial Hospital
Prostate Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Gallbladder Cancer
Melanoma
Cutaneous Melanoma
Pancreatic Cancer
Pancreatic Carcinoma
Breast Cancer
Cancer
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Elmhurst Memorial Hospital?
Elmhurst Memorial Hospital is a medical facility located in Elmhurst, Illinois. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Prostate Cancer, Adenocarcinoma and other specialties. Elmhurst Memorial Hospital is involved with conducting 91 clinical trials across 148 conditions. There are 14 research doctors associated with this hospital, such as Brian C. Myre, Maria I. Quejada, Samir D. Undevia, and Sania S. Raza.